Perspectives on the latest clinical data for targeted therapies for thyroid cancer episode artwork

EPISODE · Nov 30, 2021 · 18 MIN

Perspectives on the latest clinical data for targeted therapies for thyroid cancer

from touchPODCAST · host touchpodcast

touchMDT for touchONCOLOLOGY Listen to key experts from a multidisciplinary team discuss the latest efficacy and safety data for targeted therapies for thyroid cancer   The multidisciplinary team  Endocrinologist: Dr Antonio Matrone, Italy Nurse specialist: Ms Tara Hurley, UK Oncologist: Dr Lori Wirth, USA This touchPODCAST is for HCPs only. This activity is funded by an unrestricted independent medical education grant from Eli Lilly and Bayer. This activity is jointly provided by USF Health and touchIME. For further information visit our website: https://touchoncologyime.org/personalized-approach-to-treatment-thyroid-cancer-biomarkers-and-targeted-therapies//

Episode metadata supplied by the publisher feed · Published Nov 30, 2021

Embed this episode

Ready to play

Perspectives on the latest clinical data for targeted therapies for thyroid cancer

0:00 18:46

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of touchPODCAST?

This episode is 18 minutes long.

When was this touchPODCAST episode published?

This episode was published on November 30, 2021.

Can I download this touchPODCAST episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!